DEVELOPMENT OF SURROGATE POTENCY ASSAYS FOR CELLULAR IMMUNOTHERAPIES

被引:1
|
作者
Thakkar, A. [1 ]
Muszynski, J. [1 ]
Hall, M. W. [1 ]
Lee, D. A. [1 ]
机构
[1] Nationwide Childrens Hosp, Columbus, OH USA
关键词
D O I
10.1016/j.jcyt.2019.03.351
中图分类号
Q813 [细胞工程];
学科分类号
摘要
80
引用
收藏
页码:S32 / S32
页数:1
相关论文
共 50 条
  • [1] Proposal for the International Society for Cell & Gene Therapy position statement on assays for the quality control and potency assessment of adoptive cellular immunotherapies
    Weil, Ben
    Hanley, Patrick J.
    Lowdell, Mark
    CYTOTHERAPY, 2019, 21 (03) : 367 - 375
  • [2] Use of Immune Monitoring Assays in the Clinical Development of Immunotherapies
    Hepburne-Scott, Henry
    JOURNAL OF IMMUNOTHERAPY, 2012, 35 (09) : 759 - 760
  • [3] Accelerating the development of cellular immunotherapies therapies in the UK
    Mount, Natalie
    HUMAN GENE THERAPY, 2014, 25 (05) : A3 - A3
  • [4] Potency analysis of cellular therapies: the emerging role of molecular assays
    David F Stroncek
    Ping Jin
    Ena Wang
    Betsy Jett
    Journal of Translational Medicine, 5
  • [5] Potency analysis of cellular therapies: the emerging role of molecular assays
    Stroncek, David F.
    Jin, Ping
    Wang, Ena
    Jett, Betsy
    JOURNAL OF TRANSLATIONAL MEDICINE, 2007, 5 (1)
  • [6] Flow cytometric assays for identity, safety and potency of cellular therapies
    Campbell, John D. M.
    Fraser, Alasdair R.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2018, 94 (05) : 569 - 579
  • [7] Cellular immunotherapies
    Hallek, Michael
    INTERNIST, 2021, 62 (06): : 581 - 582
  • [8] Proposal for the International Society for Cell & Gene Therapy position statement on assays for the quality control and potency assessment of adoptive cellular immunotherapies (vol 21, pg 367, 2019)
    Welch, Angela
    CYTOTHERAPY, 2021, 23 (03) : 275 - 275
  • [9] Cellular immunotherapies for cancer
    Conall Hayes
    Irish Journal of Medical Science (1971 -), 2021, 190 : 41 - 57
  • [10] Cellular immunotherapies for cancer
    Berraondo, Pedro
    Labiano, Sara
    Minute, Luna
    Etxeberria, Inaki
    Vasquez, Marcos
    Sanchez-Arraez, Alvaro
    Teijeira, Alvaro
    Melero, Ignacio
    ONCOIMMUNOLOGY, 2017, 6 (05):